Clover Health Investments... (CLOV)
NasdaqGS: CLOV
· Real-Time Price · USD
4.60
+0.11 (2.45%)
At close: Aug 14, 2026, 3:59 PM
4.60
+0.00%
After-hours: 7:57 PM
Clover Health Investments Corp. (CLOV) Stock Price, Analysis & Data
2.45% (1D)
| Bid | 3.29 |
| Market Cap | 2.44B |
| Revenue (ttm) | 2.48B |
| Net Income (ttm) | -18.36M |
| Beta | 2.48 |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | n/a |
| Forward PE | 30.67 |
| P/B (ttm) | 6.47 |
| P/S (ttm) | 0.99 |
| Earnings Date | Nov 4, 2025 |
| Ask | 5.76 |
| Volume | 3,566,871 |
| Avg. Volume (20D) | 6,867,462 |
| Open | 4.47 |
| Previous Close | 4.49 |
| Day's Range | 4.45 - 4.63 |
| 52-Week Range | 1.58 - 5.59 |
| Analyst | Buy |
| Price Target | 5 (8.70%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware....
Industry Healthcare Plans
Sector Healthcare
IPO Date Jun 12, 2020
Employees 724
Stock Exchange NasdaqGS
Ticker Symbol CLOV
Website https://www.cloverhealth.com
Financial Performance
In 2025, Clover Health Investments's revenue was 1.92B, an increase of 40.34% compared to the previous year's 1.37B. Earnings were -85.55M, an increase of 98.91%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for CLOV stock is "Buy". The 12-month stock price forecast is 5, which is upside of 8.7% from the latest price.
Stock ForecastsEarnings Surprise
Clover Health Investments has released their quarterly earnings on Aug 5, 2026:
Clover Health Investments Corp. is scheduled to release its earnings on Nov 4, 2025, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2